DeepMind Launches AlphaGenome to Better Understand Gene Regulation
DeepMind’s AlphaGenome AI model decodes how mutations affect non-coding DNA, potentially transforming our understanding of disease.
Biotech & Health
A collection of 30 posts
Isomorphic Labs Secures $600M to Accelerate AI-Powered Drug Discovery
AI-first drug design company Isomorphic Labs has raised $600 million in its first external funding round, led by Thrive Capital, to advance its AI drug design engine and therapeutic programs.
NVIDIA and Arc Institute Introduce Evo 2, A State of the Art Foundation Model for Biology
The Arc Institute and NVIDIA unveil Evo 2, the largest AI model for biology ever, trained on 9.3 trillion DNA base pairs from over 128,000 species to advance synthetic biology, medicine, and genome design.
Latent Labs Raises $50M to Bring AI-Designed Proteins to Drug Discovery
The biotech startup founded by former DeepMind researcher Simon Kohl, has raised $50 million to develop AI models that design synthetic proteins from scratch, aiming to accelerate drug discovery and development.
OpenAI Partners with Retro Biosciences to Engineer Stem Cell Proteins with AI
OpenAI's new model, GPT-4b micro, shows promising results in redesigning proteins that could improve stem cell production efficiency by up to 50 times.
Aqemia Raises $38 Million to Propel Quantum-Powered AI Drug Discovery
Aqemia's latest funding round shows growing investor confidence in AI-powered drug discovery, as the company prepares for clinical trials and international expansion.
New Lantern Launches with $19M in Series A Funding, Unveils AI-Powered Radiology Assistant
The startup combines two essential tools radiologists use daily – medical image viewing and reporting software – into a single cloud-based platform enhanced by AI.
Google DeepMind Makes AlphaFold 3 Open Source for Academia
Now, academic researchers can download all necessary code for AlphaFold 3 inference and request access to the model parameters
Chai Discovery Releases Powerful New Open AI Model for Molecular Structure Prediction
Chai-1 enables unified prediction of proteins, small molecules, DNA, RNA, and other biomolecular structures. It matches or exceeds the performance of leading models like AlphaFold 3 on several benchmarks.
Google DeepMind Unveils Powerful New AI for Designing Protein Binders
In tests, AlphaProteo designed successful binders for seven diverse target proteins, including two involved in viral infections and five linked to cancer, inflammation, and autoimmune diseases.
Formation Bio Raises $372 Million to Develop Drugs with AI
Rather than focusing solely on drug discovery, the company acquires or in-licenses clinical-stage drugs from pharmaceutical and biotech companies.
Google Deepmind and Isomorphic Labs Announce AlphaFold 3
This new version addresses that limitation by modelling how proteins interact with a broader range of molecular partners. This includes DNA, RNA, small molecules (ligands), and even chemical modifications that play a crucial role in cellular function and disease development.
Profluent Unveils OpenCRISPR-1, an AI-Designed Gene Editor
The implications of OpenCRISPR-1 are vast and could usher in a new era of genetic medicine where treatments are not only more effective but also more accessible.
Baseimmune Closes $11.3M Series A to Accelerate AI-Designed Vaccines
Founded in 2019, Baseimmune leverages proprietary deep learning algorithms to predict future mutations of pathogens and design synthetic antigen proteins that can provide broader, longer-lasting immune protection.
Bioptimus Raises $35M Seed Funding to Build Biology Foundation Models
Bioptimus’ mission is to accelerate innovation in biomedicine using the latest advancements in AI, specifically large language models.
AI Speeds Up Hunt for New Infectious Disease Treatments
Researchers successfully used generative AI and foundation models to design several small molecule inhibitors for essential target proteins of Mycobacterium tuberculosis and coronaviruses.
Isomorphic Labs Partners with Eli Lilly and Novartis to Propel AI-Driven Drug Discovery
With a combined value of about $3B, the high-profile deals underscore the immense faith that industry leaders have in AI-driven drug discovery as the future of medicine R&D.
AI-Discovered Antibiotics Show Promise Against Deadly MRSA
Published in Nature, the study reveals that these compounds effectively eliminate MRSA in lab dishes and mouse models, while demonstrating minimal toxicity to human cells.
Elucid Secures $80 Million to Drive Adoption of AI-Powered Cardiac Imaging
The company says it will leverage the new capital to expand commercialization and clinical research efforts for its suite of cardiac imaging analysis products.
Google Teases Next Generation of AlphaFold, Expanding AI Structure Prediction Beyond Proteins
This next-generation AlphaFold signifies a dramatic leap in performance and showcases the potential of AI to enhance our understanding of molecular biology.
Google DeepMind's New AI Tool Helps Pinpoint the Causes of Genetic Diseases
In a recently published paper in Science, it was revealed that AlphaMissense had classified a staggering 89% of all possible missense variants — illuminating the pathogenic or benign nature of these mutations.
Medeloop Secures $8M to Pioneer AI-Powered Health Research
The platform aims to merge artificial intelligence with healthcare data, offering research professionals an integrated suite of tools that could radically reduce the timeline for medical discovery.
Generate:Biomedicines Closes $273 Million Series C to Advance AI-Powered Drug Pipeline
Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually.